Malcolm Lloyd-Smith, Chief Integration Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 30,636 shares at $105.82 ($3.1M) on 2023-02-06, disclosed to the SEC on 2023-02-08.
Seasonal sale ($3.1M) by Chief Integration Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.82 | 801 | $85K | 2.7% |
| 2 | $105.82 | 801 | $85K | 2.7% |
| 3 | $102.16 | 1,015 | $104K | 3.3% |
| 4 | $102.16 | 1,015 | $104K | 3.3% |
| 5 | $102.41 | 12,801 | $1.3M | 41.7% |
| 6 | $102.41 | 12,801 |
| $1.3M |
| 41.7% |
| 7 | $103.83 | 701 | $73K | 2.3% |
| 8 | $103.83 | 701 | $73K | 2.3% |
| Total | $102.64 avg | 30,636 | $3.1M | 100% |
| Filing → |
| NBIX | SELL | 2022-02-09 | $544K | — | Filing → |
| NBIX | SELL | 2021-07-29 | $3.1M | — | Filing → |
| NBIX | SELL | 2021-02-12 | $204K | — | Filing → |